Institut Curie
Clinical trials sponsored by Institut Curie, explained in plain language.
-
Aggressive treatment tested for rare bone cancer that spreads
Disease control CompletedThis study tested an intensive chemotherapy approach for Ewing sarcoma that had already spread beyond the lungs at diagnosis. It involved 45 patients aged 2-50 who received strong induction chemotherapy followed by high-dose chemotherapy with stem cell support. The goal was to se…
Phase: PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Blood test could unlock new treatment for tough breast cancers
Disease control CompletedThis study tested whether a blood test could find patients with metastatic breast cancer who might benefit from a targeted drug, even if their original tumor test suggested they wouldn't. Researchers looked for specific cancer cells in the blood of 155 patients whose cancer was c…
Phase: PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New radiation approach tested for Kids' brain cancer
Disease control CompletedThis completed Phase 3 trial compared two different radiation schedules for treating standard-risk medulloblastoma, a type of brain tumor, in children and young adults aged 4-21. All 52 participants received the same chemotherapy, but were randomly assigned to receive either stan…
Phase: PHASE3 • Sponsor: Institut Curie • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
First test: can new Drug-Radiation combo fight tough breast cancer?
Disease control CompletedThis early-stage study tested the safety of combining the drug olaparib with standard radiation therapy in patients with advanced triple-negative breast cancer. The trial involved 24 women whose cancer had not responded fully to prior chemotherapy or had returned after surgery. R…
Phase: PHASE1 • Sponsor: Institut Curie • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Scan spots 'Hidden' tumor cells to boost radiation power
Disease control CompletedThis study tested a new way to plan radiation therapy for chordomas, rare tumors of the skull base and spine. Researchers used a special PET scan to find low-oxygen areas in the tumor that are resistant to standard radiation. They then aimed to deliver a higher dose of radiation …
Phase: PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Direct-to-Brain attack on deadly breast cancer spread
Disease control CompletedThis study tested whether delivering the breast cancer drug trastuzumab (Herceptin) directly into the spinal fluid could help patients whose cancer had spread to the membranes around the brain and spinal cord. The trial involved 34 people with advanced HER2-positive breast cancer…
Phase: PHASE1, PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Blood test could personalize chemo for tough breast cancers
Disease control CompletedThis study tested whether using a blood test to track cancer cells could help doctors choose more effective chemotherapy for women with advanced breast cancer that has spread. It involved 265 women whose cancer had worsened after two prior rounds of chemotherapy. Researchers comp…
Phase: PHASE3 • Sponsor: Institut Curie • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for myeloma patients facing first relapse
Disease control CompletedThis study tested a combination of three drugs (pomalidomide, cyclophosphamide, and dexamethasone) in 100 adults with multiple myeloma whose cancer had returned after their first treatment. The goal was to see if this new drug combination could effectively control the disease in …
Phase: PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Scientists test adding a targeted drug to standard cervical cancer treatment
Disease control CompletedThis study tested if adding a targeted drug called cetuximab to the standard treatment of radiation and chemotherapy (cisplatin) was better for controlling cervical cancer. It involved 76 women with stage IB2, II, or IIIB cervical cancer who were not eligible for immediate surger…
Phase: PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated Mar 16, 2026 15:23 UTC
-
Early trial tests new combo for tough cervical cancers
Disease control CompletedThis study tested the safety of adding a new immunotherapy drug called nivolumab to the standard treatment of radiation and chemotherapy for women with locally advanced cervical cancer. It involved 21 patients and aimed to see if this combination was safe and might be more effect…
Phase: PHASE1, PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC
-
Cancer treatment tailored to your Tumor's DNA
Disease control CompletedThis study tested a personalized approach to treating advanced cancer that had stopped responding to standard treatments. Researchers analyzed the genetic makeup of each patient's tumor to find specific abnormalities. Patients were then randomly assigned to receive either a drug …
Phase: PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC
-
Scientists hunt for better prostate cancer clues in blood and urine
Diagnosis CompletedThis study aimed to find new markers in blood and urine that could help doctors better detect, predict the course of, and monitor prostate cancer. It involved 80 men, including those with prostate cancer, those suspected of having it, and healthy volunteers. Researchers collected…
Phase: NA • Sponsor: Institut Curie • Aim: Diagnosis
Last updated Mar 31, 2026 12:10 UTC
-
Finger-Prick PSA test could speed up prostate cancer checks
Diagnosis CompletedThis study tested a new, faster way to check PSA levels, a marker for prostate health. Researchers compared a simple test strip that uses a few drops of blood to the standard, more complex lab test. They wanted to see if the quick test was as accurate for monitoring patients with…
Phase: NA • Sponsor: Institut Curie • Aim: Diagnosis
Last updated Mar 30, 2026 14:29 UTC
-
New scan could tell doctors faster if breast cancer chemo is working
Diagnosis CompletedThis study tested whether a special 3D ultrasound scan, called Shear Wave Elastography, could accurately predict how well chemotherapy was shrinking tumors in patients with locally advanced breast cancer before their surgery. Researchers followed 140 patients, measuring changes i…
Phase: NA • Sponsor: Institut Curie • Aim: Diagnosis
Last updated Mar 30, 2026 14:28 UTC
-
Numbing shot before surgery could ease breast cancer pain
Symptom relief CompletedThis study tested whether a numbing injection (nerve block) given before breast cancer surgery could reduce pain afterward. Researchers compared the numbing medicine ropivacaine to a placebo (saltwater) injection in 182 women. The main goal was to see if the nerve block reduced t…
Phase: PHASE3 • Sponsor: Institut Curie • Aim: Symptom relief
Last updated Apr 03, 2026 14:41 UTC
-
New nerve block technique tested to reduce Post-Surgery pain
Symptom relief CompletedThis study compared two types of nerve blocks given before breast cancer surgery to see which better controls pain afterward. Researchers tested whether a newer technique (erector spinae block) works as well as a standard one (paravertebral block) at reducing the need for morphin…
Phase: PHASE4 • Sponsor: Institut Curie • Aim: Symptom relief
Last updated Apr 02, 2026 14:57 UTC
-
New approach aims to ease emotional burden of advanced eye cancer
Symptom relief CompletedThis study tested whether adding supportive care services early alongside standard cancer treatment helps meet patients' psychological needs better than waiting until problems arise. Researchers compared two groups of adults with metastatic uveal melanoma (eye cancer that has spr…
Phase: NA • Sponsor: Institut Curie • Aim: Symptom relief
Last updated Apr 02, 2026 14:56 UTC
-
Spray tested to soothe painful radiation burns in breast cancer patients
Symptom relief CompletedThis study tested whether a medical spray called Hydrosorb works better than a simple water spray to prevent and treat skin damage from radiation therapy in women with breast cancer. Researchers enrolled 278 women who developed mild to moderate skin redness or irritation during t…
Phase: PHASE3 • Sponsor: Institut Curie • Aim: Symptom relief
Last updated Mar 30, 2026 14:29 UTC
-
New hope to stop chronic pain after breast cancer surgery
Symptom relief CompletedThis study tested whether injecting a local anesthetic (ropivacaine) during breast cancer surgery could prevent long-term pain in the breast area. It involved 260 women who had surgery for breast cancer. Researchers compared the anesthetic injection to a placebo to see which grou…
Phase: PHASE4 • Sponsor: Institut Curie • Aim: Symptom relief
Last updated Mar 27, 2026 12:40 UTC
-
New approach to ease advanced cancer suffering shows promise
Symptom relief CompletedThis study looked at how specialized day hospital care affects the quality of life for people with advanced cancer. Researchers followed 144 patients to see if integrated palliative care helped reduce fatigue, improve emotional state, and maintain overall well-being. The goal was…
Phase: NA • Sponsor: Institut Curie • Aim: Symptom relief
Last updated Mar 24, 2026 12:01 UTC
-
Skin gel offers hope for agony of radiation burns
Symptom relief CompletedThis study looked back at medical records to see if a morphine gel applied directly to the skin helped relieve severe pain from radiation burns (radiodermatitis) in the pelvic area. It involved 17 adult cancer patients whose pain wasn't controlled by regular pain pills. The main …
Sponsor: Institut Curie • Aim: Symptom relief
Last updated Mar 16, 2026 15:27 UTC
-
Can a simple booklet help families ask the right questions about cancer?
Knowledge-focused CompletedThis study tested whether giving a booklet with example questions to patients with advanced cancer or their families before a palliative care meeting would change what they ask their doctors. Researchers wanted to see if the booklet helped people get more or different information…
Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Apr 03, 2026 18:10 UTC
-
Scientists map hidden bacteria in stubborn wounds
Knowledge-focused CompletedThis study aimed to understand why some wounds don't heal by looking for hidden layers of bacteria called biofilms. Researchers observed 130 adults with wounds lasting over 6 weeks, collecting samples to examine under microscopes. The goal was to link what they saw in the lab wit…
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:58 UTC
-
Scientists map tumor blood flow during surgery to boost future cancer treatments
Knowledge-focused CompletedThis study aimed to understand how blood flows through basal cell carcinoma skin tumors. Researchers temporarily blocked and then restored blood flow to tumors during surgical removal while measuring blood circulation changes with a special laser camera. The goal was to learn abo…
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC
-
Study reveals how breast cancer risk news impacts Women's minds and choices
Knowledge-focused CompletedThis study looked at how giving women personalized estimates of their breast cancer risk affects them psychologically. Researchers followed 405 healthy women with family histories of breast cancer who underwent genetic testing in France and Germany. The goal was to understand how…
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Scientists and dogs sniff out breast Cancer's hidden scent
Knowledge-focused CompletedThis study explored whether breast cancer has a unique smell that could be used for detection. Researchers collected odor samples from the hands, breasts, and tumors of 35 women undergoing breast cancer surgery using a special polymer. They also tested if trained dogs could ident…
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Scientists track COVID antibodies in healthcare workers for a full year
Knowledge-focused CompletedThis study followed nearly 2,000 employees from two French research institutes to understand how COVID-19 antibodies develop and change over time. Participants gave blood samples at four points over a year to measure antibody levels, and some also provided nasal swabs. The goal w…
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
New tool aims to bridge communication gap when cancer treatments stop working
Knowledge-focused CompletedThis study aimed to create a communication tool to help doctors and patients have better conversations when cancer treatments stop working. Researchers interviewed 128 people, including cancer patients, parents of children with cancer, and healthcare professionals, to understand …
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC
-
Blood test could signal Cancer's return after surgery
Knowledge-focused CompletedThis study tested whether a blood test that looks for tiny pieces of cancer DNA could help doctors monitor patients after surgery. It involved 60 people with eye melanoma that had spread to the liver, who were having surgery to remove all visible tumors. Researchers took blood sa…
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC
-
Scientists map how immune cells spot hidden cancer
Knowledge-focused CompletedThis study tested a new method to understand how the body's immune system recognizes cancer cells in lymph nodes. Researchers worked with 25 patients who had breast cancer or melanoma and were scheduled for lymph node surgery. They measured specific immune cells that target cance…
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:56 UTC
-
Scientists hunt for eye Cancer's genetic fingerprint in blood
Knowledge-focused CompletedThis study aimed to develop and compare different blood test methods to detect tiny amounts of tumor DNA from eye melanoma that has spread. Researchers worked with 40 patients whose cancer had spread to find the most sensitive and cost-effective technique. The goal was to improve…
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Mar 02, 2026 15:29 UTC